ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Has this study been replicated?
The atlas records 1 replication of this study. Recorded outcomes: 1 failed.
Replications
- Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice, LaClair et al. (2013). Outcome recorded: failed.
this drug failed to attenuate Aβ plaques or cognitive deficits in these mice.
View paper
Other studies in the atlas
Failed replications · Successful replications · All browse pages